Details of the Drug Formulations

General Information of Drug (ID: DMLOS5R)

Drug Name
BAY 80-6946 Drug Info
Synonyms
Copanlisib; BAY-80-6946; Aliqopa; UNII-WI6V529FZ9; BAY80-6946; WI6V529FZ9; AK172384; BAY 80-6946 (Copanlisib); Copanlisib [USAN:INN]; Copanlisib (USAN/INN); GTPL7875; SCHEMBL1655478; SCHEMBL13084037; Copanlisib (BAY 80-6946); DTXS
Indication
Disease Entry ICD 11 Status REF
Follicular lymphoma 2A80 Approved [1]
Non-hodgkin lymphoma 2B33.5 Approved [2]
Cross-matching ID
PubChem CID
135565596
CAS Number
1032568-63-0
TTD ID
D0S5LD
INTEDE ID
DR0378
ACDINA ID
D00965

Full List of Drug Formulations Containing This Drug

Copanlisib 60 mg For Injection
Company Formulation ID FDA Description
Bayer Healthcare Pharmaceuticals F23120 Citric Acid Anhydrous; Mannitol; Sodium Hydroxide
------------------------------------------------------------------------------------

References

1 2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)